Need Help?
Contact Us

  


92% of patients were able to stop taking warfarin 45 days post-procedure 92% of patients were able to stop taking warfarin 45 days post-procedure
99% of patients were able to stop taking warfarin within 1 year of the procedure 99% of patients were able to stop taking warfarin within 1 year of the procedure

  

WATCHMAN Facts WATCHMAN Facts



Patient Impact

See how WATCHMAN is engineered for implant success. See how WATCHMAN is engineered for implant success.


Contact us if you're interested in doing a story about WATCHMAN. Contact us if you're interested in doing a story about WATCHMAN.

Contact us for more information about WATCHMAN. Contact us for more information about WATCHMAN.

  

1. Eikelboom JW, Connolly SJ, Brueckmann M, et al. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013;369(13):1206-1214.

2. Centers for Medicare & Medicaid Services. Decision memo for percutaneous left atrial appendage (LAA) closure therapy (CAG-00445N). https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=281&ExpandComments=n&DocID=CAG-00445N&bc=gAAAAAgAAgAAAA%3d%3d&. Published February 8, 2016. Accessed May 20, 2016.

Indications, Safety and Warnings

Top